ProMIS Neurosciences, Inc. (PMN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
1920 Yonge Street
Toronto, ON M4S 3E2
Canada
Phone
416 847 6898
Sector
Healthcare
Industry
Biotechnology
Employees
7
First IPO Date
January 10, 2007
| Name | Title | Pay | Year Born |
| Neil K. Warma | Chief Executive Officer, President, Compliance Officer & Director | 604,000 | 1963 |
| Daniel E. Geffken | Chief Financial Officer | 86,263 | 1957 |
| Eugene Williams | Co-Founder & Chairman | 218,750 | 1959 |
| Larry Douglas Altstiel | Chief Medical Officer | 482,000 | 1950 |
| Johanne Kaplan | Chief Development Officer | 519,667 | 1960 |
| Neil R. Cashman | Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director | 0 | 1952 |
| Dennis Chen | Head of Manufacturing & Senior Consultant | 0 | N/A |
| David Wishart | Chief Physics Officer | 0 | N/A |
ProMIS Neurosciences, Inc. is a Canadian biotechnology firm dedicated to creating targeted therapeutic solutions for debilitating neurodegenerative conditions such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company leverages a unique computational discovery platform, utilizing its ProMIS and Collective Coordinates algorithms, to identify novel, disease-specific targets – known as epitopes – located on the surface of misfolded proteins. Its pipeline features several promising drug candidates, including PMN310, a monoclonal antibody designed to address toxic oligomers implicated in Alzheimer's disease. Another candidate, PMN267, targets superoxide dismutase 1 and TAR-DNA binding protein 43 in ALS, and alpha-synuclein associated with Parkinson's disease and Lewy body dementia. Finally, PMN442 is a monoclonal antibody aimed at toxic alpha-synuclein oligomers and seeding fibrils relevant to multiple system atrophy. Established in 2004, the company changed its name from Amorfix Life Sciences Ltd. to ProMIS Neurosciences, Inc. in July 2015. Its corporate headquarters are situated in Toronto, Canada.